Specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law
Impact
If enacted, S1243 would amend Chapter 94C of the General Laws to include strict limits on the quantities of pseudoephedrine and related substances that can be purchased within specific time frames. Retailers would be prohibited from selling more than 3.6 grams per day or 9 grams in a 30-day period to any single customer. Additionally, these products would need to be stored behind the counter or in locked cases, thus limiting customer access. By maintaining such stringent controls, the legislation seeks to mitigate the potential for abuse and illegal manufacturing of methamphetamine.
Summary
Senate Bill S1243 aims to implement a comprehensive electronic system to monitor and control the sale of products containing pseudoephedrine (PSE), a substance commonly associated with the manufacture of methamphetamine. The bill proposes that a 'real-time stop sale system' be established, which would prevent individuals from purchasing amounts that exceed federally mandated limits. This system is designed to enhance regulatory oversight, providing law enforcement agencies and pharmacies with the tools needed to track sales effectively and ensure compliance with legal requirements.
Contention
One of the central points of contention surrounding the bill involves the balance between public safety and accessibility for legitimate consumers. Proponents argue that a real-time monitoring system is pivotal for combating drug abuse and ensuring consumer protection, while opponents may view it as an overreach that could hinder access for individuals who require these medications for legitimate health needs. Furthermore, the bill includes provisions that preempt local laws, centralizing authority at the state level and potentially limiting local regulatory autonomy.
Enforcement
Enforcement of the provisions set forth in S1243 is supported through the establishment of a robust reporting system. The bill mandates that retailers submit sales data electronically and ensures that violations are categorized as misdemeanors, subject to fines. This structure not only promotes adherence to the law but also provides a mechanism for law enforcement to access sales transaction records in real-time, thus enhancing the overall effectiveness of the legal framework surrounding the sale of pseudoephedrine-containing products.
Specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law
Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.
Health: pharmaceuticals; manufacturers of products containing ephedrine or pseudoephedrine; require to participate in a national logging system. Amends secs. 7340 & 7340a of 1978 PA 368 (MCL 333.7340 & 333.7340a).
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25